treatment group 1 received a mantle of i and ii a lymphocyte predominant and nodular sclerosis plus paraaortic for i-ii a mixed cellular and lymphocyte-depleted or b symptoms ;
C0152268
nodular sclerosis
C0024264
lymphocyte